Latest Breaking News On - Journal april - Page 4 : comparemela.com

“Between 0.1%-2.0% of all child COVID-19 cases resulted in hospitalization.” Takeaway: children are rarely hospitalized and at virtually no risk of dying from COVID-19. Wherefore the need for a vaccine for an illness of far less morbidity than measles, mumps, whooping cough, etc.? Part two: Is it ethical? The safety of this vaccine long-term is not known and will not be known until at least two or more years have passed. The proposed trial will follow the children for one year following the second shot, definitely not long enough to evaluate long-term effects. A 6-month-old has no capacity to consent, and presumably a 12-year-old has none either. Therefore, a parent will have to sign a consent form. Is it ethical to allow a child to receive a vaccine for an illness that produces no or extremely mild symptoms in children with the possibility of untoward effects down the road? What if, God forbid, some of these 6,750 children slated to take part in this study develop autoimmu

United statesWalter dehorityAmerican academy of pediatricsSchool of medicineJournal aprilAmerican academyState level data reportஒன்றுபட்டது மாநிலங்களில்அமெரிக்கன் கலைக்கழகம் ஆஃப் குழந்தை மருத்துவம்பள்ளி ஆஃப் மருந்துஇதழ் ஏப்ரல்அமெரிக்கன் கலைக்கழகம்நிலை நிலை தகவல்கள் அறிக்கை